Avm Biotechnology Inc
Clinical trials sponsored by Avm Biotechnology Inc, explained in plain language.
-
New drug option opens for Hard-to-Treat cancers
Disease control AVAILABLEThis program provides access to an experimental drug called AVM0703 for people with various solid tumors or blood cancers who have not responded to other treatments. It is available in the US upon a doctor's request. So far, 37 patients have received the drug, and side effects ha…
Sponsor: AVM Biotechnology Inc • Aim: Disease control
Last updated May 26, 2026 09:38 UTC
-
New drug aims to control blood cancers in early trial
Disease control Recruiting nowThis study tests a new drug called AVM0703 in people with certain blood cancers (lymphoid malignancies). The goal is to see if it is safe and can shrink tumors. About 144 people aged 12 and older will receive a single infusion of the drug. The study is currently recruiting.
Phase: PHASE1, PHASE2 • Sponsor: AVM Biotechnology Inc • Aim: Disease control
Last updated May 18, 2026 12:01 UTC